Lọc tín hiệu
MKV

MKV

Cai Lay Veterinary Pharmaceutical
PharmaceuticalsHNX
Same sector:AGPAMPBCHBCPBIOCDPCNCDANDBDDBM
14.500
+9,85%
2026-10-12

Fundamental Analysis

41 / 100BRubric: Manufacturing
Quarterly resultsRelative Valuation
CriterionLatest Q EPS growth (YoY)Avg EPS growth, last 3 (YoY)Quarters with EPS growthRevenue growth (YoY)Gross margin change (pp, YoY)Net margin change (pp, YoY)Return on Equity (TTM)Financial health (Debt/Equity)Valuation (P/E vs 5-yr median)Revenue (bn)Rev YoYNPAT (bn)NPAT YoYP/E5-Year Median P/EP/E vs. 5-Year Median
Value-48.5%+852.6%1 / 3+4.6%-2.89 pp-3.41 pp+14.4%0.004.8735,4+4,6%1,2−48,5%4.877.71−36,9%
Pts012404001212
Valuation annotation:Price: 14.500 (close price on 2026-10-12)EPS (TTM): 2.978

Financial charts

1.Revenue & growth

VND bn35,4Q2/26

1.Revenue & growth

VND bn35,4Q2/26

2.Profit & growth

VND bn1,17Q2/26

3.Profit mix (Penman)

VND bn18,6Q2/26

4.Margins & cost structure

%34.2%Q2/26

5.Returns & cash cycle

% · days25.4%Q2/26

6.Earnings quality & cash

VND bn

7.Asset structure

VND bn122Q2/26

8.Funding & debt health

VND bn · times122Q2/26

9.Revenue backlog

VND bn0,04Q2/26

10.Valuation

times · %4,9×Q2/26

11.EPS growth & dilution warning (CANSLIM)

VND per share; growth in %234Q2/26
Adjusted EPS growth, latest quarter
-48.5%
Average adjusted EPS growth, 3 quarters
853%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%

Source: vnstockData through Q2/26